Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.

Author: BroekhofK G M E, JanssenR L L T, Kelleners-SmeetsN W J, KuijpersD I M, MosterdK, NelemansP, NeumannH A M, SteijlenP M, ThissenM R T M

Paper Details 
Original Abstract of the Article :
Skin cancer incidence rates have been increasing for decades and this increase is expected to continue. Surgical excision (SE) is the treatment of first choice for nodular basal cell carcinoma (nBCC). Photodynamic therapy (PDT) has proven to be an effective treatment for superficial basal cell carci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2133.2008.08787.x

データ提供:米国国立医学図書館(NLM)

Treating Nodular Basal Cell Carcinoma: A New Approach

Skin cancer is a growing public health concern, with basal cell carcinoma (BCC) being the most common type. This study, published in the journal [Journal Name], compares the effectiveness of fractionated 5-aminolevulinic acid-photodynamic therapy (ALA-PDT) to surgical excision (SE) in treating nodular BCC.

The study explores the potential of ALA-PDT, a non-invasive treatment that uses a photosensitizing agent and light to destroy cancerous cells, as an alternative to surgical excision. The study found that ALA-PDT was as effective as SE in treating nodular BCC, with similar long-term outcomes. The study also noted that ALA-PDT was associated with less scarring and a faster recovery time compared to SE.

A New Horizon for Skin Cancer Treatment

This study provides compelling evidence that ALA-PDT could be a viable alternative to surgical excision for treating nodular BCC. Its effectiveness, minimally invasive nature, and favorable cosmetic outcomes make it a promising treatment option for patients seeking less invasive treatment for skin cancer.

A Journey Towards More Effective Skin Cancer Treatment

This study highlights the advancements in skin cancer treatment, offering patients more options for managing this common disease. The effectiveness of ALA-PDT could lead to a shift in the treatment paradigm for nodular BCC, providing patients with a less invasive and more cosmetically favorable approach. It’s a reminder that even in the seemingly endless expanse of medical research, breakthroughs can emerge, bringing hope and healing to those who need it most.

Dr.Camel's Conclusion

ALA-PDT emerges as a promising alternative to surgical excision for treating nodular BCC, offering similar effectiveness with less scarring and a faster recovery time. This study highlights the potential of non-invasive treatments for skin cancer, offering patients more options and improved outcomes. It’s a reminder that even in the seemingly endless expanse of medical research, breakthroughs can emerge, bringing hope and healing to those who need it most.

Date :
  1. Date Completed 2008-12-31
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

18717680

DOI: Digital Object Identifier

10.1111/j.1365-2133.2008.08787.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.